tirzepatide mode of action Tirzepatide, a New Era Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review tirzepatide.pptx

A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone

Yes, gradual tapering helps minimize side effects and cravings

Titration Start tirzepatide alone for 8 weeks, then add cagrilintide at 0.25 mg/week

Novo also reported detecting oxidized peptide fragments, semaglutide aggregates, truncated peptide chains, and formaldehyde related adducts in certain samples

Written by: Morgan Pennington , 07 Jan 2025 5 min read Reviewed and fact-checked: Niya Mansuri , Prescribing Pharmacist, GPhC No

Most members receive compounded medications 2-9 business days after provider approval